Cochrane Abstracts
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Standard Versus Biofilm Antimicrobial Susceptibility Testing to Guide Antibiotic Therapy in Cystic Fibrosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Systemic_antibiotics_for_treating_diabetic_foot_infections_New. Accessed 19 April 2024.
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Systemic_antibiotics_for_treating_diabetic_foot_infections_New. Accessed April 19, 2024.
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Systemic_antibiotics_for_treating_diabetic_foot_infections_New
Standard Versus Biofilm Antimicrobial Susceptibility Testing to Guide Antibiotic Therapy in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Systemic_antibiotics_for_treating_diabetic_foot_infections_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
ID - 437546
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Systemic_antibiotics_for_treating_diabetic_foot_infections_New
DB - Evidence Central
DP - Unbound Medicine
ER -
